FDA
approval
· 2017-04-24
FDA Approved: OLMESARTAN MEDOXOMIL — Original Application (QUALLENT PHARMACEUTICALS HEALTH LLC)
Summary
The FDA approved an original abbreviated new drug application (ANDA) for olmesartan medoxomil, with Quallent Pharmaceuticals Health LLC as the applicant.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for OLMESARTAN MEDOXOMIL (OLMESARTAN MEDOXOMIL)